Latest News and Press Releases

-- Following positive efficacy and safety results from Phase 2b QUALITY study, company received FDA regulatory clarity for enobosarm in combination with GLP-1 RA -- -- Incremental weight loss is an...

Ratutrelvir shows a differentiated profile versus PAXLOVID™ with fewer adverse events and no viral rebounds Activity shown in Paxlovid®-ineligible patients, representing a significant population with...

City of Fresno deploys seven Beam Global EV ARC™ off-grid charging systems to power its municipal EV fleet with renewable energy.

BEIJING, Dec. 17, 2025 (GLOBE NEWSWIRE) -- 36Kr Holdings Inc. ("36Kr" or the "Company") (NASDAQ: KRKR), a prominent brand and pioneering platform dedicated to serving New Economy participants in...

WALTHAM, Mass., Dec. 17, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and...

REYKJAVÍK (17. DESEMBER 2025) - Alvotech (NASDAQ: ALVO, ALVO SDB) tilkynnti í dag að fyrirtækið hefði selt breytanleg skuldabréf að fjárhæð 108 milljónir bandaríkjadala til hóps um 20 alþjóðlegra...

THIS PRESS RELEASE MAY NOT BE DISTRIBUTED, RELEASED, OR PUBLISHED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH...

Nyxoah Annonce le Lancement Commercial de la Thérapie Innovante Genio® Aux Pays-BasPremières implantations Genio réalisées avec succès dans les hôpitaux OLVG West et Zuyderland Mont-Saint-Guibert,...

Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the NetherlandsFirst Genio implants successfully performed at OLVG West and Zuyderland hospitals Mont-Saint-Guibert, Belgium –...

SAN JOSE, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (Nasdaq: SYNA) today announced that it will showcase a broad portfolio of AI-native processing, sensing, and connectivity...